Journal of Medicinal Chemistry · 2013 · 153 citations · 84 references
Life SciencesMedicinal ChemistryMolecular BiologyDrug DiscoveryGene ExpressionHost-pathogen InteractionsBacterial Virulence FactorsEnzyme InhibitionMicrobial Virulence FactorsPathogen Virulence FactorsQuorum SensingVirulence Gene RegulationTranscription InhibitorsTranscriptional Regulation Of Virulence GenesTwo-component Regulatory SystemsTwo-component Signal Transduction SystemsTwo-component Signaling SystemsVirulence Factor ExpressionVirulence Factor RegulationVirulence Gene Expression
Virulence gene expression in Staphylococcus aureus is tightly regulated by intricate networks of transcriptional regulators and two-component signal transduction systems. There is now an emerging body of evidence to suggest that the blockade of S. aureus virulence gene expression significantly attenuates infection in experimental models. In this Perspective, we will provide insights into medicinal chemistry strategies for the development of chemical reagents that have the capacity to inhibit staphylococcal virulence expression. These reagents can be broadly grouped into four categories: (1) competitive inhibitors of the accessory gene regulator (agr) quorum sensing system, (2) inhibitors of AgrA-DNA interactions, (3) RNAIII transcription inhibitors, and (4) inhibitors of the SarA family of transcriptional regulators. We discuss the potential of specific examples of antivirulence agents for the management and treatment of staphylococcal infections.
84
Bacterial Interference Caused by Autoinducing Peptide Variants
Guangyong Ji, Ronald C. Beavis, Richard P. Novick · Science · 1997 · 804 citations
Shu Y. Queck, Max Jameson‐Lee, Amer E. Villaruz et al. · Molecular Cell · 2008 · 583 citations · Full text